LNTH
Lantheus Holdings
Data as of 2026-07-21
Company attributes
Price
Interactive 5-year price history chart for LNTH. Latest close $107.95.
Pillar breakdown
0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)
- QualityProfit margins & asset efficiency78ExceptionalHealth Care median (n=166) 50
- ValuePrice vs fundamentals44AverageHealth Care median (n=166) 52
- GrowthRevenue & earnings trajectory79ExceptionalHealth Care median (n=166) 50
- MomentumRecent price strength86ExceptionalHealth Care median (n=166) 49
- HealthBalance sheet & solvency79ExceptionalHealth Care median (n=166) 57
- ProfitabilityROE, ROA, ROIC74ExceptionalHealth Care median (n=166) 48
- TechnicalTrend & volatility signals47AverageHealth Care median (n=166) 56
- RiskVolatility & drawdown profile49AverageHealth Care median (n=166) 46
Pillars not shown: Sentiment, ML (Phase 5+).
Risk Summary
Low- Accruals momentum (Δ TATA > 0.05 over 3y)[accruals_momentum_high]
Rolls up Phase 4.5 earnings-manipulation defenses (Sloan · Beneish · Dechow · REM · restatement · late-filing · earnings- quality time-series) into a single 0-100 risk index. The soft composite penalty (max 10 pts) is informational only — the ranking uses the raw composite score per project Rule 16.
Fair price check
4 different valuation methods each estimate what LNTHshould be worth, then we compare to today's price.
- P/E multiplesFairthinks it's fairly priced — estimates $118.05, about 9% above today
- P/B multiplesOvervaluedthinks it's expensive — estimates $36.81, about 66% below today
- Graham (defensive)Outlierestimate looks unreliable — estimates $19.54 — likely unreliable
- Residual IncomeOutlierestimate looks unreliable — estimates $9.26 — likely unreliable
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
- Median fair
- $28.17
- Margin of safety(vs fair value)
- < −99%
- Max (ex-outliers)
- $118.05
- Tangible BVPS
- $4.10
- Goodwill-heavy balance sheet
- Extreme Graham estimate
- Extreme Residual-Income estimate
- Accruals momentum
Median of all applicable methods (current price $107.95). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.
Supporting dataRaw fundamentals & data-quality provenance behind the scores above
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $7.03B |
| Revenue (TTM) | $1.55B |
| Net income (TTM) | $279.03M |
| Operating cash flow (TTM) | $407.70M |
| CapEx (TTM) | $45.34M |
| Free cash flow (TTM)CFO − CapEx | $362.36M |
| Total assets | $2.35B |
| Total liabilities | $1.13B |
| Stockholders' equity | $1.21B |
| Cash & equivalents | $498.58M |
| Shares outstanding | 65.11M |
| EPS (basic) | $4.29 |
| EPS (diluted) | $4.29 |
| P/E ratio (TTM) | 25.19 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-05-07
- Latest period end
- 2026-05-01
- Filing lag
- 75 days
- Missing metrics
- 3(depreciation_and_amortization, dividends_paid, ebitda)
Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.